<p>Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.</p>

Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.

<p>Lecia Sequist, MD, MPH of Massachusetts General Hospital &amp; Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC &amp; her campaign for the IASLC Board of Directors.</p>

Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLC

Dr. Jack West reviews emerging new information and controversial topics in health care in general, cancer treatment in particular.

Share Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLC

Sign up to save your podcasts

Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLC

Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLC